Recurrent Pleural Effusion and a Mediastinal Mass

Respiration ◽  
2000 ◽  
Vol 67 (4) ◽  
pp. 471-472 ◽  
Author(s):  
F. Herrmann ◽  
F. Reichenberger ◽  
U. Leupold ◽  
M. Steinert ◽  
J. Schauer
Keyword(s):  
Pleural Effusion ◽  
Mediastinal Mass ◽  
Recurrent Pleural Effusion

scholarly journals Mutiloculated thymic cyst: unusual presentation of mediastinal mass

2019 ◽  
Vol 6 (2) ◽  
pp. 56-59
Author(s):  
Uttam Laudari ◽  
Shreya Bhandari ◽  
Rupesh Ramtel ◽  
Bibhuti Adhikari ◽  
Mohan Dev Bhandari
Keyword(s):  
Pleural Effusion ◽  
Mediastinal Mass ◽  
Thymic Cyst ◽  
Mediastinal Cyst ◽  
Rare Presentation ◽  
Mediastinal Masses ◽  
Thymic Neoplasm ◽  
Immunocompromised State ◽  
Work Up ◽  
Recurrent Pleural Effusion

Here we present a case of 47 year male found to have large multiloculated thymic cyst during work up done for recurrent pleural effusion. Mediastinal cyst constitutes 10-15% of all radiographically detected mediastinal masses. Thymic cyst account only 5% of mediastinal masses. Thymic cyst can cause difficulty in diagnosis due to its rare presentation, invasive nature and occasional associated with thymic neoplasm. They have been detected incidentally and associated with Sjögren’s syndrome, aplastic anemia myasthenia gravis and immunocompromised patients. Here we present a case of 47-year-old male initially work up done for recurrent pleural effusion turned out to be large multilocuated thymic cyst improved after excision which had no associated syndromes and immunocompromised state.

Delayed effusive pericarditis and recurrent pleural effusion after radiation treatment for Hodgkin's disease responsive to per os doxycycline

2006 ◽  
Vol 76 (2) ◽  
pp. 176-179 ◽  
Author(s):  
Konstantinos N. Fragoulis ◽  
Eleni Handrinou ◽  
Vasilis Papadopoulos ◽  
Konstantinos Dardoufas ◽  
Matthew E. Falagas
Keyword(s):  
Pleural Effusion ◽  
Hodgkin's Disease ◽  
Radiation Treatment ◽  
Hodgkin’S Disease ◽  
Recurrent Pleural Effusion

Mediastinal Mass With Accompanying Pleural Effusion- An Uncommon Presentation of Pancreatic Pseudocyst

CHEST Journal ◽  
2015 ◽  
Vol 148 (4) ◽  
pp. 501A
Author(s):  
Chidozie Agu ◽  
Frances Marie Schmidt ◽  
Lamont Brown ◽  
Rawshan Ali Basunia ◽  
Bikash Bhattarai ◽  
...  
Keyword(s):  
Pleural Effusion ◽  
Pancreatic Pseudocyst ◽  
Mediastinal Mass ◽  
Uncommon Presentation

scholarly journals Experience of lodopovidone Pleurodesis at A Tertiary Care Hospital in Peshawar

1969 ◽  
Vol 11 (3) ◽  
pp. 123-127
Author(s):  
Muhammad Umar ◽  
Zia Ul Haq ◽  
Imtiaz Khan ◽  
Anila Basit ◽  
Amin Ul Haq ◽  
...  
Keyword(s):  
Pleural Effusion ◽  
Malignant Pleural Effusion ◽  
Tertiary Care Hospital ◽  
Tertiary Care ◽  
Care Hospital ◽  
Efficacy And Safety ◽  
Chemical Pleurodesis ◽  
Effective Agent ◽  
Age Range ◽  
Recurrent Pleural Effusion

Background: Chemical pleurodesis is used for the management of malignant /recurrent pleural effusion and pneumothorax.Malignant pleural effusion is diagnosed on histopathology or malignant cells in pleural fluid. Pneumothorax is diagnosed by chestradiograph. Pleurodesis can be performed surgically or by using medical agents. Various pleurodesis agents have been used e.g.Tetracycline.Bleomycin. Talc and lodopovidone with different success and complications rates.Objective: This study was conducted to know the efficacy and safety of lodopovidone as pleurodesis agent in themanagement of pleural effusion (malignant/recurrent) and recurrent pneumothorax.Material and Methods: This was a descriptive study conducted at department of Pulmonology Lady Reading HospitalPeshawar from February 2018 to May 2019.Results:A Total of 213 patients were included in the study, among which 120 (56.3%) were males and 93 (43.6%) werefemales. Age range was from 20 to 83 years. One hundred and thirty eight patients (74.8%) had malignant pleural effusion and75 (35.2%) had recurrent pneumothorax. The success rate with lodopovidone pleurodesis was 85 % (181) as a whole with afailure rate of 13 %( 28) in pleural effusion and 2 %( 4) in pneumothorax. Chest pain (65.7%) was the most common side effectfollowed by fever (24.4%) and dyspnea (12.2%).No serious side effects were observed in this study.Conclusion: lodopovidone is easily available, safer, cheaper and effective agent for chemical pleurodesis in pneumothorax,malignant/recurrent pleural effusion.Keywords: Pleurodesis, lodopovidone. Malignant, Pleural Effusion, Pneumothorax.

Recurrent Pleural Effusion Associated with Dysgammaglobulinemia

CHEST Journal ◽  
1973 ◽  
Vol 63 (4) ◽  
pp. 635-636 ◽  
Author(s):  
W.J. Godfrey ◽  
Joseph W. Sokolowski
Keyword(s):  
Pleural Effusion ◽  
Recurrent Pleural Effusion
Sign in / Sign up

Export Citation Format

Share Document